This program provides practical information for for participants to be able to initiate an SGLT2i for their heart failure patients and incorporate therapy in an optimal timeframe. 

Accreditation Statement

In accordance with ACCME policy, prior to participating in this activity, you must review the information on this page.

Joint Accreditation


In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement
Physicians

The ACCF designates this MOD for a maximum of up to 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

While offering the CME credits noted above, this program is not intended to provide extensive training or certification in the field.

MOC Information

Successful completion of this CME/CNE/MOC activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.

Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurses
The ACCF designates this educational activity for a maximum of 1.5 continuing nursing education contact hours.  Nurses should only claim credit commensurate with the extent of their participation in the activity.

Pharmacists

ACCF designates this continuing education activity for 1.5 contact hours 1.5 CEUs of the Accreditation Council for Pharmacy Education.

 This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

While offering credits noted above, the course is not intended to provide extensive training or certification in this field.

Target Audience:

CV team clinicians including physicians, nurse practitioners, physician assistants and pharmacists who manage patients with heart failure. 

Important Dates:
Date of Release: April 4, 2022
Term of Approval/Date of Expiration: April 4, 2023

Learner Objectives:
Upon completion of this activity, you should be able to:

• Identify the clinical indications and key considerations for selection of SGLT2 inhibitors for heart failure patients
• Establish a contemporary prescribing timeline including initiation, dosing, and monitoring of SGLT2 inhibitors

Acknowledgements:
Educational grant support provided by: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

To request credit, you must:

• Read all text and view all tables and/or figures in the case for which you wish to receive credit.
• Answer the questions in each case for which you wish to claim credit. After you have answered all the questions, click on the Exam Summary button. A Claim Credit button will appear on this page if you have achieved a passing score of 70% or better. If you did not achieve a passing score, please click the Reset Scores link and retake the exam.
• Click the Claim Credit button and answer the evaluation questions in the pop-up window.
• Enter the total amount of time you actually spent in the activity in the box provided. Please note that you may only claim once for each module in this activity. Click Submit.
• You will receive a message that your request has been submitted and a link to view your certificate. You may view and download the certificate when you receive the message, you may also view it at any time in the My Transcript section of My ACC.

This CME/CNE/MOC-certified activity may contain links to other educational resources such as clinical trial summaries, journal articles, guidelines, etc., that may not be CME-certified. Please note that clicking on the links provided to view these resources will open new windows, which are outside of this CME/CNE/MOC-certified activity.

Faculty:

Alison Bailey, MD, FACC
James L. Januzzi, MD, FACC
Nosheen Reza, MD, FACC
Shashank Sinha, MD, FACC
Muthiah Vaduganathan, MD, FACC

Peer Reviewer:

Alison Bailey, MD, FACC

Learner Objectives
Upon completion of this program, you should be able to:

• Identify the clinical indications and key considerations for selection of SGLT2 inhibitors for heart failure patients
• Establish a contemporary prescribing timeline including initiation, dosing, and monitoring of SGLT2 inhibitors